Obermatt
See Similar Stocks →

Jade Biosciences

NAQ:JBIO · US0080642061
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book38
Dividend Yield1
Revenue Growth—
Profit Growth97
Capital Growth73
TSR 52w90
Leverage95
Liquidity58
Refinancing49
Combined—
Analyst Opinions100
Pro Holdings83
Opinion Changes50
Market Pulse7

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Websitejadebiosciences.com
ISINUS0080642061
Last UpdateApr 2, 2026
Index & Theme
RheumatologyInflammationNephrologyImmunologyHealth CareTherapeutics

Description

Jade Biosciences, Inc., a clinical-stage biopharmaceutical company, develops novel biologic therapies for patients living with autoimmune diseases. The company’s approach is to discover, and efficiently develop, biologics that address emerging targe…

Similar Stocks

The companies this stock is ranked against.

Compare Jade Biosciences with its peers
Ardelyx
NMQ:ARDX
82
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Vera Therapeutics
NMQ:VERA
44
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Xencor
NMQ:XNCR
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Soleno Therapeutics
NAQ:SLNO
67
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Aurinia Pharmaceuticals
NMQ:AUPH
85
CountryCanada
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mink Therapeutics
NAQ:INKT
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →